Purification of a polysaccharide from Boschniakia rossica and its synergistic antitumor effect combined with 5-Fluorouracil
► Boschniakia rossica is a traditional Chinese herbal medicine. ► A polysaccharide was prepared and its chemical analysis was preliminarily made. ► BRP alone or combined with 5-FU could inhibit S180 tumor growth. ► Damage to the immune system caused by 5-FU in S180-bearing mice was mitigated by BRP....
Saved in:
Published in | Carbohydrate polymers Vol. 89; no. 1; pp. 31 - 35 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier Ltd
05.06.2012
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ► Boschniakia rossica is a traditional Chinese herbal medicine. ► A polysaccharide was prepared and its chemical analysis was preliminarily made. ► BRP alone or combined with 5-FU could inhibit S180 tumor growth. ► Damage to the immune system caused by 5-FU in S180-bearing mice was mitigated by BRP. ► BRP combined with 5-FU presented synergistic effects on antitumor activity in S180 tumor bearing mice.
Current study we purified a polysaccharide (BRP) from Boschniakia rossica and the antitumor effects of BRP alone or combined with 5-Fluorouracil (5-FU) was examined in S180 tumor bearing mice by intragastric administration. The high performance size-exclusion chromatography (HPGEC) analysis showed that BRP was a homogeneous polysaccharide and had a molecular weight of 2.2×104Da. Total carbohydrate content in BRP was determined to be 96.9%, without the presence of protein and nucleic acid. BRP alone or combined with 5-FU could significantly inhibit Sarcoma-180 (S180) tumor growth and increase the spleen index in a dose-dependent manner. Meanwhile a synergistic effect was observed in boosting various immunity functions when the tumor bearing mice receiving BRP plus 5-FU administration, such as stimulating lymphocytes proliferation, increasing NK cell cytotoxicity, enhancing serum interleukin-2 (IL-2) and interferon-gamma (TNF-γ) secretion, as well as augmenting CD4+ and CD8+ spleen T lymphocytes subsets. The results showed that BRP combined with 5-FU presented synergistic effects on antitumor activity in tumor bearing mice. In conclusion, the combination of BRP may boost the suppressed immunity in tumor bearing mice subject to 5-FU chemotherapy, and could serve as a new, promising approach for cancer treatment. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.carbpol.2012.02.024 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0144-8617 1879-1344 1879-1344 |
DOI: | 10.1016/j.carbpol.2012.02.024 |